Volume 10, Issue 2 (2011) Perspectives
Article
Why Brand Pharmaceutical Companies Choose to Pay Generics in Settling Patent Disputes: A Systematic Evaluation of Asymmetric Risks in Litigation
Xiang Yu and Anjan Chatterji
Note
Podcast with Drew Clark
Drew Clark discusses The Overly Active Corpse of Red Lion published in NJTIP Issue 9.3 and national broadband plan.